Bactericidal composition for preventing and treating wheat sharp eyespot

Through the combination of gummytoxin and benzoneflucazole or thifuroamide, a new bactericidal composition is formed, which solves the problem of resistance to wheat striatum blight, achieves efficient prevention and treatment effects and reduces environmental pollution. Target.

CN118923683AActive Publication Date: 2024-11-12HENAN HANSI CROP PROTECTION
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202410987373.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-23
Publication Date
2024-11-12
Estimated Expiration
2044-07-23

AI Technical Summary

Technical Problem

Wheat blight is resistant to existing fungicides, resulting in a decrease in the prevention and treatment effect year by year, and there is a lack of effective compound formula to delay the generation of drug resistance and improve the prevention and treatment effect.

Method used

Combining gummytoxin with benzoenylflucazole or thiofuramide in a specific mass ratio to form a new bactericidal composition for the development of efficient bactericidal agents for the prevention and control of wheat streptobacteria and adding them to the bactericidal agents. Auxiliary ingredients to improve effect.

Benefits of technology

The bactericidal composition exhibits synergistic effects within a certain mass ratio range, improving the prevention and treatment effect of wheat striatum blight, reducing the amount of agent used and environmental pollution, and reducing the risk of pathogenic bacteria resistance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004957828740000031
    Figure BDA0004957828740000031
  • Figure BDA0004957828740000041
    Figure BDA0004957828740000041
  • Figure BDA0004957828740000042
    Figure BDA0004957828740000042
Patent Text Reader

Abstract

The invention belongs to the technical field of prevention and treatment of wheat sharp eyespot, and particularly relates to a bactericidal composition for preventing and treating wheat sharp eyespot. The invention relates to a bactericidal composition. The bactericidal composition is prepared by compounding gliotoxin and benzovindiflupyr or thifluzamide. The gliotoxin and the benzovindiflupyr or the thifluzamide which have different action mechanisms are compounded according to a certain mass ratio, a synergistic bactericidal effect is shown in a certain mass ratio range, and the gliotoxin and the benzovindiflupyr can be used for developing an efficient bactericide for preventing and treating wheat sharp eyespot.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of wheat sheath blight prevention and treatment, and particularly relates to a bactericidal composition for preventing and treating wheat sheath blight. Background Art

[0002] Gliotoxin (CAS: 67-99-2) is a cyclic diamino acid secondary metabolite extracted from the fermented mycelium of Trichoderma, which has an inhibitory effect on most plant pathogenic fungi. Zhejiang University first discovered that gliotoxin has a significant preventive and therapeutic effect on rice sheath blight, and later studies have found that gliotoxin has a significant killing and inhibitory effect on soil-borne diseases.

[0003] Both benzovinflumizole and thiofluanid belong to the succinate dehydrogenase inhibitor (SDHI) class of fungicides, which are inhibitors of pathogen respiration. They inhibit the function of mitochondria by interfering with the tricarboxylic acid cycle on complex II of the respiratory electron transport chain, preventing them from producing energy, inhibiting the growth of pathogens, and ultimately causing their death. Benzovinflumizole and thiofluanid are systemic and have a long lasting effect, and can be used to prevent and control a variety of crop diseases.

[0004] Wheat sheath blight, also known as wheat sharp eyespot disease, is a soil-borne fungal disease of wheat distributed worldwide. In actual production, both Rhizoctonia cerealis and Rhizoctonia solani can cause wheat sheath blight. Although a stable source of resistance to wheat sheath blight has been obtained, there are few resistant varieties. In production, chemical control mainly relies on seed treatments such as triadimefon, fenpropimorph and tebuconazole combined with spring spraying. However, with the extensive use of fungicides and the continuous use of similar agents, the sensitivity of wheat sheath blight to multiple agents has decreased or different degrees of resistance have been developed, and the control effect has declined year by year.

[0005] The use of existing fungicide active ingredients for compounding, among which the compound formula with synergistic effect can delay the development of bacterial resistance, improve the actual prevention effect, expand the fungicide spectrum and reduce the cost of drug use, which is an important means of preventing and controlling crop diseases. However, there is no report on the use of fungicide compositions with gliotoxin and benzovindiflupyr or thiophanate-methyl as active ingredients for the prevention and control of wheat sheath blight.

[0006] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention and should not be regarded as an acknowledgment or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art. Summary of the invention

[0007] The object of the present invention is to provide a fungicide composition for preventing and controlling wheat sheath blight, which can improve the prevention and control effect on wheat sheath blight and delay the generation of drug resistance of pathogenic bacteria.

[0008] To achieve the above object, the present invention provides the following technical solutions:

[0009] A fungicide composition for preventing and treating wheat sheath blight is prepared by compounding gliotoxin with benzovinflumizone or thiophanate-methyl.

[0010] More specifically, the mass ratio of gliotoxin to benzovindiflupyr is 1-10:10-1.

[0011] More specifically, the mass ratio of gliotoxin to thiothiocarb is 1-3:20-1.

[0012] The present invention also provides a bactericide, which comprises auxiliary components and the bactericidal composition.

[0013] Specifically, the auxiliary component is selected from one or more of a wetting agent, a dispersant, a disintegrant, an emulsifier, a solvent, an inert filler, a thickener, a defoaming agent and a preservative.

[0014] Compared with the prior art, the present invention has the following beneficial effects:

[0015] (1) The present invention mixes gliotoxins with different action mechanisms with benzovinflumizone or thiophanate-methyl in a certain mass ratio, and exhibits a synergistic fungicidal effect within a certain mass ratio range, and can be used to develop a highly effective fungicide for preventing and controlling wheat stripe blight.

[0016] (2) Compared with single benzovinflumizone or thiophanate-methyl, the fungicide composition of the present invention can improve the control effect on wheat sheath blight, thereby reducing the amount of the agent used, alleviating environmental pollution, and having good safety. It can also reduce the risk of drug resistance of pathogens. DETAILED DESCRIPTION

[0017] The following is a clear and complete description of the technical solution of the patent of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by technicians in this field without creative work are within the scope of protection of the present invention.

[0018] Example :Screening of control agents

[0019] 1. Test strains

[0020] Wheat plants with typical symptoms of wheat sheath blight were collected, isolated, purified and Koch's postulates were verified in the experiment, and the pathogen was determined to be Rhizoctonia cerealis, which was stored on PSA culture medium.

[0021] Inoculate Rhizoctonia graminearum into the center of the PSA medium, culture it at 25°C for 3 days, and set it aside.

[0022] 2. Test reagents

[0023] 98% Gliotoxin TC, 96% Benzovindiflupyr TC, 96% Thiofluanid TC.

[0024] After the test agent is completely dissolved in dimethyl sulfoxide, it is diluted with 0.1% Tween-80 aqueous solution to form a single-dose stock solution. Multiple groups of ratios are set up, and each single-dose stock solution and the ratio mixture are diluted with 0.1% Tween-80 aqueous solution to set up 5 mass concentration gradients.

[0025] 3. Test methods

[0026] The mycelial growth rate method was used to determine the toxicity of single-dose stock solutions and mixed solutions to the test strain Fusarium graminearum.

[0027] Mix 9mL of pre-melted PSA medium and 1mL of the test agent in a sterile conical flask, pour into a culture dish with a diameter of 9cm, and make a drug-containing plate of the corresponding concentration; and use the PSA plate with the same volume of 0.1% Tween-80 aqueous solution as the blank control, and set up 5 replicates for each treatment. Use a hole puncher to cut a 5mm diameter bacterial cake from the edge of the test strain colony after the expansion culture, and inoculate it in the center of the drug-containing plate and the blank control plate, with the mycelium facing down, and inoculate 1 bacterial cake per dish. Cover the dish and place it in a 25℃ constant temperature box for culture. When the diameter of the blank control colony grows to about 6-7cm, measure the colony diameter using the cross method, and calculate the inhibition rate of mycelium growth by different treatments.

[0028]

[0029] 4. Data Analysis

[0030] DPS software was used for data statistical analysis. The logarithmic value of fungicide concentration was taken as x and the corresponding probability value of mycelium growth inhibition rate was taken as y for linear regression. The toxicity regression equation and the toxicity EC value of the agent to the target pathogen were obtained. 50 The co-toxicity coefficient (CTC) was calculated according to the Sun Yunpei method.

[0031]

[0032] In the above formula: ATI--the toxicity index of the mixture; S--the EC of the standard agent 50 , the unit is mg / L; M--EC of the mixture 50 , unit is mg / L.

[0033] TTI=TI A ×P A +TIB ×P B

[0034] In the above formula: TTI-theoretical toxicity index of the mixture; TI A --Toxicity index of A agent; P A --The percentage of agent A in the mixture, in percentage (%); TI B --Toxicity index of agent B; P B --The percentage of agent B in the mixture, in percentage (%).

[0035]

[0036] In the above formula: CTC--co-toxicity coefficient; ATI--actual toxicity index of the mixture; TTI--theoretical toxicity index of the mixture.

[0037] 5. Measurement results

[0038] The synergistic effect of the drug was evaluated based on the calculated co-toxicity coefficient (CTC). CTC≤80 was antagonistic, 80<CTC<120 was additive, and CTC≥120 was synergistic. The results are shown in Table 1-2.

[0039] Table 1 Indoor bioactivity test of gliotoxin and benzovinflumizone against wheat sheath blight pathogen

[0040] Drug name and ratio <![CDATA[EC 50 (mg / L)]]> ATI TTI CTC Gliotoxin 67.5916 100.0000 -- -- Benzovinflumizole 8.0372 840.9844 -- -- Gliotoxin 1: Benzovindiflupyr 10 5.7645 1172.5492 773.6222 151.5661 Gliotoxin 1: Benzovindiflupyr 7 3.2457 2082.4968 748.3614 278.2742 Gliotoxin 1: Benzovindiflupyr 3 6.3641 1062.0763 655.7383 161.9665 Gliotoxin 1: Benzovindiflupyr 1 10.6003 637.6386 470.4922 135.5258 Gliotoxin 3: Benzovindiflupyr 1 18.9312 357.0381 285.2461 125.1684 Gliotoxin 7: Benzovindiflupyr 1 24.8496 272.0028 192.6231 141.2099 Gliotoxin 10: Benzovindiflupyr 1 33.1909 203.6450 167.3622 121.6792

[0041] As shown in Table 1, after the active ingredient gliotoxin is compounded with benzovinflumizone, the co-toxicity coefficient against wheat sheath blight pathogen is greater than 120 in the mass ratio range of 1-10:10-1, showing a synergistic effect.

[0042] Table 2 Indoor bioactivity determination of gliotoxin and thiophanate-methyl against wheat sheath blight pathogen

[0043] Drug name and ratio <![CDATA[EC 50 (mg / L)]]> ATI TTI CTC Gliotoxin 67.5916 100.0000 -- -- Thifluzamide 1.3967 4839.3785 -- -- Gliotoxin 1: Thiofuramide 20 1.2018 5624.1970 4613.6938 121.9023 Gliotoxin 1: Thiofuramide 10 0.8951 7551.2904 4408.5259 171.2883 Gliotoxin 1: Thiofuramide 7 1.0918 6190.8408 4246.9562 145.7712 Gliotoxin 1: Thiofuramide 3 1.1946 5658.0948 3654.5339 154.8240 Gliotoxin 1: Thiofuramide 1 2.1475 3147.4552 2469.6893 127.4434 Gliotoxin 3: Thiofuramide 1 4.2473 1591.4016 1284.8446 123.8595

[0044] As shown in Table 2, after the active ingredient gliotoxin is compounded with thiophanate-methyl, the co-toxicity coefficient against wheat sheath blight pathogen is greater than 120 in the mass ratio range of 1-3:20-1, showing a synergistic effect.

[0045] In summary, the present invention compounds gliotoxin with different action mechanisms with benzovinflumazole or thiophanate-methyl in a certain mass ratio, and exhibits a synergistic bactericidal effect within a certain mass ratio range, which can be used to develop a highly effective bactericide for preventing and treating wheat sheath blight. In addition, compared with single benzovinflumazole or thiophanate-methyl, the bactericidal composition of the present invention can improve the control effect on wheat sheath blight, based on which the amount of the agent used can be reduced, environmental pollution can be reduced, and safety is good. And the risk of drug resistance of pathogens can be reduced.

[0046] The foregoing description of specific exemplary embodiments of the present invention is for the purpose of illustration and demonstration. These descriptions are not intended to limit the present invention to the precise form disclosed, and it is clear that many changes and variations can be made based on the above teachings. The purpose of selecting and describing the exemplary embodiments is to explain the specific principles of the present invention and its practical application, so that those skilled in the art can realize and utilize various different exemplary embodiments of the present invention and various different selections and changes. The scope of the present invention is intended to be limited by the claims and their equivalents.

Claims

1. A fungicidal composition for preventing and treating wheat sheath blight, characterized in that: The bactericidal composition is prepared by compounding gliotoxin with benzovinflumizone or thiophanate-methyl.

2. The bactericidal composition according to claim 1, characterized in that The mass ratio of the gliotoxin to benzovintriazole is 1-10:10-1.

3. The bactericidal composition according to claim 1, characterized in that The mass ratio of the gliotoxin to thiophanate-methyl is 1-3:20-1.

4. A bactericide, characterized in that: The bactericide comprises auxiliary components and the bactericidal composition according to claim 1.

5. The bactericide according to claim 4, characterized in that The auxiliary ingredients are selected from one or more of wetting agents, dispersants, disintegrants, emulsifiers, solvents, inert fillers, thickeners, defoamers and preservatives.

Citation Information

Patent Citations

  • Gliotoxin missible oil preparation

    CN105010360A

  • Composition containing gliotoxin

    CN105494369A

  • Sterilizing composition containing gliotoxin and pyrazol indanyl formamide

    CN106106479A

  • Application of two gliotoxins in preparation of biopesticide

    CN106818793A

  • Bactericidal composition containing gliotoxin and fenhexamid

    CN107711857A